M2e, human TFA

The M2e peptide, comprising the conserved 23-residue extracellular domain of influenza A M2 protein, is a universal vaccine candidate. Its high sequence conservation across human strains makes it valuable for research in immunology and vaccine development, supporting both in vitro binding studies and in vivo challenge models.